SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is a major trending topic, propelled by recent speculation around a significant supply deficit, surging industrial demand from AI and green energy, and China's upcoming export restrictions from early next year. The community is actively discussing a potential historic short squeeze, with many anticipating continued parabolic price action, while some traders are hedging against a possible short-term pullback in this intensely watched commodity.

A SPAC III Acquisition Corp. is a blank check company. The company was created for the purpose of effecting a merger, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on September 3, 2021 and is headquartered in Hong Kong.

A SPAC III Acquisition Corp. - Ordinary Shares - Class A

Alpha Capital Acquisition Co - Ordinary Shares - Class A

Alpha Capital Acquisition Co. (ASPC) is actively trending as a low-float SPAC, driving intense discussion and trading activity within the community. Traders are eyeing its potential for a short squeeze due to reported high short interest and limited shares, though many also caution about its history of significant volatility and quick reversals.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending amid community discussion regarding China's recent sanctions, widely seen as a bullish validation of its strategic importance in the defense sector. This comes as the U.S. implements a ban on foreign-made drones and components, fueling expectations for substantial defense budget allocations and significant contract awards for American-made small drones and unmanned surface vessels. The company's increasing production capacity is highlighted as a critical factor in capturing this anticipated demand.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space Inc. (FJET) is trending as a low-float IPO benefiting from renewed interest in the broader space sector. The community is actively discussing extremely high borrow fees and limited short availability, fueling strong speculation about a significant short squeeze. However, some investors express caution regarding the company's long-term fundamentals and potential for future share dilution.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending amidst surging global silver prices, particularly hitting new highs in Shanghai, which has fueled widespread community frustration over AG's perceived lag and market manipulation. Despite this, investors are bullishly anticipating a significant "catch-up" rally for the stock, driven by strong underlying silver fundamentals and recent company updates, viewing the current disconnect as a prime buying opportunity for substantial upside potential.

Coupang, Inc. engages in the provision of retail, restaurant delivery, video streaming, and fintech services to customers around the world under brands that include Coupang, Coupang Eats, Coupang Play, and Farfetch. It operates through the Product Commerce and Developing Offerings segments. The Product Commerce segment consists of the company's core retail and marketplace offerings and Rocket Fresh, its fresh grocery category offering. It also includes advertising products associated with these offerings. The Developing Offerings segment covers the company's more nascent offerings and services including: Coupang Eats, a restaurant ordering and delivery service in Korea, Coupang Play, an online content streaming service in Korea, fintech services, retail operations in Taiwan, as well as advertising products associated with these offerings. It also includes Farfetch, a global luxury fashion marketplace. The company was founded by Bom Kim in 2010 and is headquartered in Seattle, WA.

Coupang Inc - Ordinary Shares - Class A

Coupang Inc 

Coupang is heavily trending due to a significant customer data breach that has triggered intense government scrutiny and a recent leadership change. While some community members voice strong concerns over potential consumer boycotts, lawsuits, and severe regulatory penalties, others contend the actual impact may be less severe than initially feared, viewing the stock as oversold. The e-commerce giant's dominant position in South Korea is now being tested by these evolving operational and reputational challenges.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is trending as its energy-efficient APU chip gains attention following independent validation for AI workloads, positioning it as a potential disruptor in edge computing for drones and defense. While many investors are enthusiastic about its compute-in-memory architecture and recent government contracts, a strong debate exists within the community regarding its commercial viability and future prospects.

Amprius Technologies, Inc. engages in the development, manufacture, and market lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the United States and Rest of the World geographical segments. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending amid a CEO transition aimed at scaling operations and recent expansion of its South Korea Battery Alliance, significantly boosting its global production capacity. The community is actively discussing the stock's recent price volatility, attributing it to broader market conditions and tax-loss harvesting, while maintaining a long-term bullish outlook due to institutional interest and anticipation of key contracts within the growing high-energy battery market for aerospace, drones, and potential orbital AI applications.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is a trending topic following a major contract win from the Space Development Agency, which significantly boosts its backlog and solidifies its role as a defense prime. This has ignited strong bullish sentiment within the community, with many anticipating continued upside, while others point to potential overvaluation and recent insider sales as reasons for caution. The company's expanding space systems capabilities and the broader sector's momentum are key discussion points among investors.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital is trending as investors grapple with its significant underperformance, consistently lagging Bitcoin's recent upward movements, which fuels widespread frustration over management and dilution. Despite bearish sentiment, a segment of the community highlights institutional accumulation and the company's strategic pivot into AI/HPC data centers as potential long-term catalysts, contrasting with immediate concerns around options expirations and tax loss harvesting pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$LFCR &quot;Heads up alert! Upcoming earnings on Monday, 10/13/2025 for $LFCR 
Neutral (5.4) 
 
--- 
Financial Analysis: 
Lifecore Biomedical (LFCR) is currently navigating a period of strategic growth and market engagement, as evidenced by its recent activities in the investor and industry conference circuits. 
The company&#39;s recent stock performance, marked by a notable 10.8% increase, suggests positive investor sentiment, potentially driven by favorable earnings estimate revisions. 
However, the upcoming earnings report looms as a critical juncture, with concerns about the company&#39;s ability to deliver an earnings beat. 
The P/E ratio for LFCR remains an essential metric to watch, as it reflects market expectations relative to its earnings. 
While the current P/E ratio is not explicitly available, the upward revision in earnings estimates might indicate a favorable adjustment. 
The EPS growth trajectory will be crucial in determining the company&#39;s financial health and future stock performance, especially given its position in the competitive CDMO sector. 
Revenue forecasts are anticipated to align with industry trends, which show moderate growth in demand for contract manufacturing services. 
In comparison to its industry peers, Lifecore&#39;s intrinsic value, estimated at approximately 44% above its current share price, suggests an undervaluation, presenting a potential opportunity for long-term investors. 
This valuation is based on a two-stage Free Cash Flow to Equity model, highlighting the company&#39;s strategic financial positioning and potential for value realization. 
 
Earnings Report Expectations: 
As Lifecore prepares to release its Q1 earnings report, the market is keenly observing key financial metrics that could influence stock performance. 
Historically, LFCR&#39;s earnings have been a mixed bag, with occasional beats and misses. 
Analyst consensus estimates suggest that the company may not meet earnings expectations this quarter, which could impact the stock negatively if confirmed. 
The market will be looking for clarity on revenue growth, margin improvements, and any strategic initiatives that could bolster future earnings potential. 
The potential impact of the earnings report on the stock will depend heavily on the company&#39;s ability to manage investor expectations and provide a robust outlook for subsequent quarters. 
 
Sector Performance: 
The sector in which Lifecore operates, primarily focusing on contract development and manufacturing organizations (CDMO), has been experiencing steady growth due to increased outsourcing trends in the pharmaceutical industry. 
The demand for efficient and scalable manufacturing solutions continues to rise, driven by pharmaceutical companies&#39; need to optimize costs and focus on core competencies. 
Within this context, Lifecore&#39;s ongoing participation in industry conferences signifies its proactive approach to capturing market opportunities and enhancing its competitive positioning. 
The sector&#39;s overall performance remains robust, with a positive outlook driven by innovation, regulatory approvals, and an expanding global healthcare market. 
 
- Funds were net buyers of $LFCR during the previous reporting quarter. 
 
- Funds with large holdings in $LFCR include: 
 
- Last 10 days performance: -2% 
- Last 30 days performance: -6% 
- Last 90 days performance: -22% 
 
Some of the latest news articles: 
 - Title: Lifecore Biomedical (LFCR) May Report Negative Earnings: Know the Trend Ahead of Q1 Release 
Publication Date: 9/26/2025 2:00:02 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/lifecore-biomedical-lfcr-may-report-140002064.html?.tsrc=rss 
 
 - Title: Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 
Publication Date: 9/23/2025 8:30:00 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/lifecore-announces-inducement-grant-under-203000341.html?.tsrc=rss 
 
 - Title: Lifecore Biomedical (LFCR) Soars 10.8%: Is Further Upside Left in the Stock? 
Publication Date: 9/12/2025 1:09:00 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/lifecore-biomedical-lfcr-soars-10-130900522.html?.tsrc=rss 
 
 - Title: Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference 
Publication Date: 9/4/2025 8:05:00 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/lifecore-biomedical-participate-24th-annual-200500631.html?.tsrc=rss 
 
Follow us on stocktwits.com for more earnings alerts. Not a financial advice. Not a trading signal.&quot;

Lifecore Biomedical (LFCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo Finance

Lifecore Biomedical (LFCR) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

CHASKA, Minn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc.

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Lifecore Biomedical (LFCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Lifecore Biomedical (LFCR) Soars 10.8%: Is Further Upside Left in the Stock?

CHASKA, Minn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organization ("CDMO"), today announced that the company will participate at the 24th Annual Contract Pharma Contracting and Outsourcing Conference.

Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference

Stocktwits provides real-time stock, crypto & international market data to keep you up-to-date. Find top news headlines, discover your next trade idea, share & gain insights from traders and investors from around the world, build a watchlist, buy US stocks, & create and manage your portfolio.

Stocktwits

Stocktwits - Stock Market Live Quotes, Social Community Discussions, News, Stock Rankings & Earnings

StockTwits Web

Lifecore Biomedical Inc

 "Heads up alert! Upcoming earnings on Monday, 10/13/2025 for 

 
Neutral (5.4) 
 
--- 
Financial Analysis: 
Lifecore Biomedical (LFCR) is currently navigating a period of strategic growth and market engagement, as evidenced by its recent activities in the investor and industry conference circuits. 
The company's recent stock performance, marked by a notable 10.8% increase, suggests positive investor sentiment, potentially driven by favorable earnings estimate revisions. 
However, the upcoming earnings report looms as a critical juncture, with concerns about the company's ability to deliver an earnings beat. 
The P/E ratio for LFCR remains an essential metric to watch, as it reflects market expectations relative to its earnings. 
While the current P/E ratio is not explicitly available, the upward revision in earnings estimates might indicate a favorable adjustment. 
The EPS growth trajectory will be crucial in determining the company's financial health and future stock performance, especially given its position in the competitive CDMO sector. 
Revenue forecasts are anticipated to align with industry trends, which show moderate growth in demand for contract manufacturing services. 
In comparison to its industry peers, Lifecore's intrinsic value, estimated at approximately 44% above its current share price, suggests an undervaluation, presenting a potential opportunity for long-term investors. 
This valuation is based on a two-stage Free Cash Flow to Equity model, highlighting the company's strategic financial positioning and potential for value realization. 
 
Earnings Report Expectations: 
As Lifecore prepares to release its Q1 earnings report, the market is keenly observing key financial metrics that could influence stock performance. 
Historically, LFCR's earnings have been a mixed bag, with occasional beats and misses. 
Analyst consensus estimates suggest that the company may not meet earnings expectations this quarter, which could impact the stock negatively if confirmed. 
The market will be looking for clarity on revenue growth, margin improvements, and any strategic initiatives that could bolster future earnings potential. 
The potential impact of the earnings report on the stock will depend heavily on the company's ability to manage investor expectations and provide a robust outlook for subsequent quarters. 
 
Sector Performance: 
The sector in which Lifecore operates, primarily focusing on contract development and manufacturing organizations (CDMO), has been experiencing steady growth due to increased outsourcing trends in the pharmaceutical industry. 
The demand for efficient and scalable manufacturing solutions continues to rise, driven by pharmaceutical companies' need to optimize costs and focus on core competencies. 
Within this context, Lifecore's ongoing participation in industry conferences signifies its proactive approach to capturing market opportunities and enhancing its competitive positioning. 
The sector's overall performance remains robust, with a positive outlook driven by innovation, regulatory approvals, and an expanding global healthcare market. 
 
- Funds were net buyers of 

 during the previous reporting quarter. 
 
- Funds with large holdings in 

 include: 
 
- Last 10 days performance: -2% 
- Last 30 days performance: -6% 
- Last 90 days performance: -22% 
 
Some of the latest news articles: 
 - Title: Lifecore Biomedical (LFCR) May Report Negative Earnings: Know the Trend Ahead of Q1 Release 
Publication Date: 9/26/2025 2:00:02 PM, Source: yahoo 
URL: 

 
 
 - Title: Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 
Publication Date: 9/23/2025 8:30:00 PM, Source: yahoo 
URL: 

 
 
 - Title: Lifecore Biomedical (LFCR) Soars 10.8%: Is Further Upside Left in the Stock? 
Publication Date: 9/12/2025 1:09:00 PM, Source: yahoo 
URL: 

 
 
 - Title: Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference 
Publication Date: 9/4/2025 8:05:00 PM, Source: yahoo 
URL: 

 for more earnings alerts. Not a financial advice. Not a trading signal."